Pubet Weeranawin

Pubet Weeranawin

Auto-generated profile, based on publicly available information

Pubet Weeranawin

Division of Gastroenterology, Department of Medicine, Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok, Thailand

Research Focus & Metrics

Academic Career Length

2Years (2025-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
31 October 2026 in Intestinal Research
Verified
Journal Article
Open access
PDF file
PWPubet Weeranawin
Pubet Weeranawin
TGTanawat Geeratragool
Tanawat Geeratragool
WKWanruchada Katchamart
Wanruchada Katchamart
JLJulajak Limsrivilai
Julajak Limsrivilai
Background/Aims: Diagnosis of intestinal tuberculosis (ITB) is challenging. Histopathology and microbiological examination remain the gold standard, but previous studies show varied diagnostic performance. We aimed to systematically evaluate the accuracy of tests to diagnose ITB in both conventional and novel methods. Methods: We searched MEDLINE and EMBASE from inception to October 2023. All studies enrolling at least 10 patients with reported information regarding the diagnosis of ITB based on endoscopic biopsy specimens, stool tests, and blood tests were included. We performed a meta-analysis using a random-effects model to estimate the performance of each test. Results: Of 3,308 abstracts reviewed, 55 studies with 6,072 participants met the inclusion criteria. Endoscopic tissue biopsy for acid-fast bacilli, the presence of caseous granuloma on histopathology, polymerase chain reaction (PCR) for tuberculosis, mycobacterial culture, and Xpert MTB/RIF showed pooled sensitivity of 12% (95% confidence interval [CI], 8%–17%), 18% (95% CI, 12%–27%), 58% (95% CI, 44%–72%), 23% (95% CI, 12%–40%) and 29% (95% CI, 17%–46%), respectively. The liquid medium culture showed higher sensitivity than conventional Lowenstein-Jensen medium (25% [95% CI, 13%–43%] and 6% [95% CI, 3%–13%]). Pooled sensitivity and specificity of stool PCR for TB were 73% (95% CI, 43%–90%) and 95% (95% CI, 79%–99%), respectively. Additionally, the pooled sensitivity and specificity of interferon-gamma release assay (IGRA) were 86% (95% CI, 79%–91%) and 86% (95% CI, 81%–89%). Conclusions: Endoscopic tissue biopsy samples had limited sensitivity in diagnosing ITB. IGRA showed good accuracy and may be combined with other methods to improve the diagnostic yield. Stool PCR demonstrated a good performance but based on a few studies.

27 August 2026 in Clinical and Translational Gastroenterology
Verified
Journal Article
Open access
TGTanawat Geeratragool
Tanawat Geeratragool
TATHANAPAT ATTHAKITMONGKOL
THANAPAT ATTHAKITMONGKOL
STSupathep Tansirichaiya
Supathep Tansirichaiya
PWPubet Weeranawin
Pubet Weeranawin
SLSomchai Leelakusolvong
Somchai Leelakusolvong
MMMonthira Maneerattanaporn
Monthira Maneerattanaporn
INTRODUCTION: Rapid urease test (RUT) is widely used for diagnosing Helicobacter pylori (HP) because it is inexpensive and practical. However, its accuracy is reduced in peptic ulcer bleeding (PUB). We prospectively performed a head-to-head comparison of diagnostic tests in the same patients to evaluate their performance in this setting. METHODS: After endoscopic hemostasis, gastric biopsies were obtained for RUT, histology, and polymerase chain reaction (PCR). Blood samples were collected for current infection marker and antiurease antibody. Urea breath testing (UBT) was performed in patients with negative RUT and histology. Diagnostic performance was assessed using a composite reference standard defined by at least 2 positive results among RUT, histology, PCR, and UBT. Logistic regression was used to identify factors associated with false-negative RUT. RESULTS: A total of 135 patients with PUB were enrolled, of whom 36 (26.7%) were HP-positive. Sensitivity/specificity was 69.4%/97.0% for RUT, 55.6%/96.0% for histology, 97.2%/92.9% for PCR, 77.8%/77.8% for current infection marker, and 83.3%/62.6% for antiurease antibody. Combining RUT, histology, and either PCR or UBT increased sensitivity to 100% and significantly outperformed RUT alone ( P = 0.021 and P = 0.001, respectively). PCR reduced idiopathic ulcers from 31.9% to 26.7%. Only 43 of 98 patients with negative RUT and histology underwent UBT because of clinical constraints, limiting its practicality despite excellent performance. No predictors of false-negative RUT were identified. DISCUSSION: In PUB, tissue PCR showed the best overall diagnostic performance among the single tests. RUT alone is insufficient for diagnosing HP, whereas combined testing with RUT, histology, and PCR or UBT achieved the highest diagnostic performance.

1 January 2026 in Translational Gastroenterology and Hepatology
Verified
Journal Article
Open access
NPNutchanun Preechakawin
Nutchanun Preechakawin
MSMets Suttikulsombat
Mets Suttikulsombat
PKPattarachai Kiratisin
Pattarachai Kiratisin
PWPubet Weeranawin
Pubet Weeranawin
MMMonthira Maneerattanaporn
Monthira Maneerattanaporn
Although nosocomial diarrhea other than Clostridioides difficile infection (CDI) is common, only limited evidence on antidiarrheal medications has been studied. Probiotics, known for preventing antibiotic-associated diarrhea (AAD) by restoring microbiota and bismuth subsalicylate (BSS), a traditional medication with anti-microbial and anti-secretory effects are interested to be used. We then conducted randomized controlled trial (RCT) to evaluate the use of Saccharomyces boulardii (S. boulardii) versus BSS as an adjunctive treatment for nosocomial diarrhea. This is a prospective RCT conducted at Department of Medicine, Siriraj Hospital, Bangkok, Thailand. Patients with new onset nosocomial diarrhea and negative C. difficile toxin in stool were randomly allocated to receive 5 days of either S. boulardii (Sb group) or BSS (BSS group), compared to standard care (SC group). Treatment outcomes including stool weight, frequency and consistency were compared between groups. Seventy-two eligible patients were recruited from August 2016 to February 2018. Demographic data in these three groups were comparable. The median changes of stool weight from baseline to day 5 of treatment between the groups were not significantly different (Sb 68 vs. BSS 170 vs. SC 156 g, P=0.11). Median change of stool frequency (Sb 0.9 vs. BSS 1.0 vs. SC 1.6 times/day, P=0.14) and consistency were similar (Sb 0.2 vs. BSS 0.4 vs. SC 0.2, P=0.95). No adverse event was reported. Our study revealed that S. boulardii and BSS added no benefit in treatment of non-CDI nosocomial diarrhea. These were applicable across all outcomes including weight, frequency and consistency of stool. More studies are needed to ascertain a better treatment for nosocomial diarrhea. Thai Clinical Trials Registry Identifier TCTR20250904004.

30 September 2025 in Clinical Endoscopy
Verified
Journal Article
Open access
TCTHANABOON CHAEMSUPAPHAN
THANABOON CHAEMSUPAPHAN
PWPubet Weeranawin
Pubet Weeranawin
RKRonnakorn Kongsakon
Ronnakorn Kongsakon
SNSupot Nimanong
Supot Nimanong
SPSitanun Preechathaveekid
Sitanun Preechathaveekid
UKUayporn Kaosombatwattana
Uayporn Kaosombatwattana
Aggressive systemic mastocytosis: unraveling the mystery behind chronic diarrhea